CN101675806A - 一种成年人abcodac组合胶囊最佳营养补充剂 - Google Patents
一种成年人abcodac组合胶囊最佳营养补充剂 Download PDFInfo
- Publication number
- CN101675806A CN101675806A CN200810071754A CN200810071754A CN101675806A CN 101675806 A CN101675806 A CN 101675806A CN 200810071754 A CN200810071754 A CN 200810071754A CN 200810071754 A CN200810071754 A CN 200810071754A CN 101675806 A CN101675806 A CN 101675806A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- acid
- aliphatic acid
- health
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 30
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 46
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 34
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 34
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 34
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 32
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 32
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 230000036541 health Effects 0.000 claims abstract description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 17
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 17
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 17
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 17
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims abstract description 17
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 17
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 17
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 17
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract description 17
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 17
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 17
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 17
- 239000011648 beta-carotene Substances 0.000 claims abstract description 17
- 229960002747 betacarotene Drugs 0.000 claims abstract description 17
- 229960002685 biotin Drugs 0.000 claims abstract description 17
- 235000020958 biotin Nutrition 0.000 claims abstract description 17
- 239000011616 biotin Substances 0.000 claims abstract description 17
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 17
- 239000011575 calcium Substances 0.000 claims abstract description 17
- 239000000460 chlorine Substances 0.000 claims abstract description 17
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 17
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960001231 choline Drugs 0.000 claims abstract description 17
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 17
- 239000011651 chromium Substances 0.000 claims abstract description 17
- 239000010941 cobalt Substances 0.000 claims abstract description 17
- 229910017052 cobalt Inorganic materials 0.000 claims abstract description 17
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052802 copper Inorganic materials 0.000 claims abstract description 17
- 239000010949 copper Substances 0.000 claims abstract description 17
- 239000011737 fluorine Substances 0.000 claims abstract description 17
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 17
- 229960000304 folic acid Drugs 0.000 claims abstract description 17
- 235000019152 folic acid Nutrition 0.000 claims abstract description 17
- 239000011724 folic acid Substances 0.000 claims abstract description 17
- 229960000367 inositol Drugs 0.000 claims abstract description 17
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 17
- 229910052742 iron Inorganic materials 0.000 claims abstract description 17
- 239000011777 magnesium Substances 0.000 claims abstract description 17
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 17
- 229910052750 molybdenum Inorganic materials 0.000 claims abstract description 17
- 239000011733 molybdenum Substances 0.000 claims abstract description 17
- 239000011574 phosphorus Substances 0.000 claims abstract description 17
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 17
- 239000011591 potassium Substances 0.000 claims abstract description 17
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 17
- 229960003471 retinol Drugs 0.000 claims abstract description 17
- 235000020944 retinol Nutrition 0.000 claims abstract description 17
- 239000011607 retinol Substances 0.000 claims abstract description 17
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011669 selenium Substances 0.000 claims abstract description 17
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 17
- 229910052718 tin Inorganic materials 0.000 claims abstract description 17
- 239000011701 zinc Substances 0.000 claims abstract description 17
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 17
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 16
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 16
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 16
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 16
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 16
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 16
- 239000010703 silicon Substances 0.000 claims abstract description 16
- 235000015097 nutrients Nutrition 0.000 claims abstract description 13
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 12
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 12
- 239000011719 vitamin A Substances 0.000 claims abstract description 12
- 229940045997 vitamin a Drugs 0.000 claims abstract description 12
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 10
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 10
- 239000011710 vitamin D Substances 0.000 claims abstract description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 10
- 229940046008 vitamin d Drugs 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 8
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000011135 tin Substances 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims description 34
- 125000001931 aliphatic group Chemical group 0.000 claims description 34
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 16
- 229910052720 vanadium Inorganic materials 0.000 claims description 16
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims description 16
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 15
- 229960003966 nicotinamide Drugs 0.000 claims description 15
- 235000005152 nicotinamide Nutrition 0.000 claims description 15
- 239000011570 nicotinamide Substances 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 12
- 235000013343 vitamin Nutrition 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 9
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 239000011630 iodine Substances 0.000 claims description 9
- 229910052748 manganese Inorganic materials 0.000 claims description 9
- 239000011572 manganese Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000007887 hard shell capsule Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000013402 health food Nutrition 0.000 claims description 5
- 230000007115 recruitment Effects 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 3
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960002061 ergocalciferol Drugs 0.000 claims description 2
- 235000001892 vitamin D2 Nutrition 0.000 claims description 2
- 239000011653 vitamin D2 Substances 0.000 claims description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 229920001875 Ebonite Polymers 0.000 claims 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims 3
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- -1 nisiloy Chemical compound 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 17
- 235000013305 food Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 235000019175 phylloquinone Nutrition 0.000 abstract 1
- 239000011772 phylloquinone Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 abstract 1
- 229960001898 phytomenadione Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003912 environmental pollution Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000454168 Cranionycta oda Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940098086 niacinamide 30 mg Drugs 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000002220 organoid Anatomy 0.000 description 1
- 229940080093 pantothenic acid 100 mg Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- RMDJVOZETBHEAR-LQYWTLTGSA-N vitamin D5 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C RMDJVOZETBHEAR-LQYWTLTGSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种成年人ABCODAC组合胶囊最佳营养补充剂。所述的一种成年人ABCODAC组合胶囊最佳营养补充剂是以维生素A：视黄醇、β－胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega－6脂肪酸、EPA/DHAomega－3脂肪酸、钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴38种营养素组合的全营养素保健食品。成年人ABCODAC组合胶囊最佳营养补充剂是以21世纪最新营养科学结合最新医学科学为基本原理，国际创新的最佳营养补充配方，是促使国人健康，预防富贵病，消灭亚健康，延长健康寿命的最佳良方。A型组合胶囊适宜普健康与轻度亚健康人群，B型组合胶囊适宜中度亚健康人群、C型组合胶囊适宜重度亚健康与疾病人群。
Description
技术领域
本发明属于一种成年人ABC三类不同健康状况人群最佳营养补充保健食品
背景技术
保健食品的发展是衡量一个国家或地区人民的健康程度和生活质量的鲜明特征之一。随着生活水平提高和社会活动节奏加快，精神压力、工作压力、环境污染与生活方式不佳，缺乏运动，偏营养饮食习惯，传统的非健康烹调方式，使维生素必须脂肪酸大量的损失，能量营养素大量过剩，维生素、矿物质，必需脂肪酸和抗氧化物质的缺乏量剧增，富贵病(现代文明病)越来越多，亚健康状况越来越严重，生活水平大幅提高，健康水平反而下降。另一方面是随着科学水平的高速发展，地下能源的大量开发利用，二氧化碳排放量大幅增加，气侯环境变暖，全球环境受到严重污染，从空气、水源、噪声、光源、电磁波、化学工业、汽车尾气、农药化肥、土壤、食物、食物连等受到不同程度的污染，食物生长期缩短，食物原料自然反营养物质与环境污染的反营养物质剧增，药品抗生素类的反营养物质，生活方式不佳引起的反营养物质也同时剧增，严重影响了人类饮食的营养与健康，人类体内自身合成功能的退化，各种营养素损耗指数的增加，人体的营养消耗量也大幅增加，为了洁抗环境污染、精神压力、工作压力、抗生素药类，不佳的生活方式，人类必须要消耗大量的营养元素，人体的必需营养素缺泛量越来越大，这是抵抗与免疫产生的自然现象，国家的推荐量(DRIS)与现代国际最佳营养的研究差距越来越大。我们研究的ABCDRIS健康饮食项目与ABCODAC最佳营养补充项目是一对同胞姐妹项目，随着营养科学和医学科学的不断发展，人类的健康必须要采用ABCDRIS健康饮食和ABCODAC最佳营养补充，结合最佳科学健康的生活方式(优美环境、适量运动，充足睡眠、心态平衡，生活规律、安全卫生、预防污染、防灾抗灾、灾难自救等)这样人类才会健康与长寿，国人健康国家强盛。
发明内容
本发明的目的在于弥补现有污染环境下与现有膳食习惯中营养素的明显不足，缺乏量很大的情况下，来补充人类各种人群的健康营养，使各类人群能达到最佳营养，更是创造了一种现代健康理想的营养补充剂保健食品。
本发明的目的是这样实现的：所述的一种成年人ABCODAC组合胶囊最佳营养补充剂是以维生素A：视黄醇、β-胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega-6脂肪酸，EPA/DHAomega-3脂肪酸，钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴38种营养素组合的全营养素保健食品。
1、A型组合胶囊适宜普健康与轻度亚健康人群，具体原料配方包括如下：维生素A：视黄醇600-1000ug、β-胡萝卜素900-1500ug、维生素D2.25-3.75ug、E112.5-187.5mg、K115-25ug、C600-1000mg、B111.25-18.75mg、B211.25-18.75mg、B633.75-56.25mg、B127.5-12.5ug、烟酰胺18.75-31.25mg、泛酸22.5-37.5mg、叶酸150-250ug、生物素22.5-37.5ug、胆碱22.5-37.5mg、肌醇22.5-37.5mg、GLAomega-6脂肪酸75-125mg、EPA/DHAomega-3脂肪酸187.5-312.5mg、钙150-250mg、铁4.5-7.5mg、镁37.5-62.5mg、锌4.5-7.5mg、碘45-75ug、铜225-375ug、磷18.75-31.25mg、硒18.75-31.25ug、铬18.75-31.25ug、锰1.5-2.5mg、钾75-125mg、钼75-125ug、氯7.5-12.5mg、氟300-500ug、镍3-5ug、硅6-10ug、锡6-10ug、钒6-10ug、钴0.3-0.5ug。
2、B型组合胶囊适宜中度亚健康人群，具体原料配方包括如下：维生素A：视黄醇1200-2000ug、β-胡萝卜素1800-3000ug、维生素D3-5ug、E150-250mg、K118.75-31.25ug、C1200-2000mg、B118.75-31.25mg、B218.75-31.25mg、B645-75mg、B1215-25ug、烟酰胺22.5-37.5mg、泛酸37.5-62.5mg、叶酸225-375ug、生物素45-75ug、胆碱30-50mg、肌醇30-50mg、GLAomega-6脂肪酸112.5-187.5mg、EPA/DHAomega-3脂肪酸375-625mg、钙225-375mg、铁7.5-12.5mg、镁75-125mg、锌9-15mg、碘75-125ug、铜450-750ug、磷37.5-62.5mg、硒56.25-93.75ug、铬37.5-62.5ug、锰3-5mg、钾112.5-187.5mg、钼120-200ug、氯15-25mg、氟450-750ug、镍3.75-6.25ug、硅7.5-12.5ug、锡7.5-12.5ug、钒7.5-12.5ug、钴0.45-0.75ug。
3、C型组合胶囊适宜重度亚健康与疾病人群，具体原料配方包括如下：维生素A：视黄醇1500-2500ug、β-胡萝卜素2250-3750ug、维生素D3.75-6.25ug、E225-375mg、K122.5-37.5ug、C1500-2500mg、B126.25-43.75mg、B226.25-43.75mg、B656.25-93.75mg、B1222.5-37.5ug、烟酰胺30-50mg、泛酸75-125mg、叶酸300-500ug、生物素90-150ug、胆碱37.5-62.5mg、肌醇37.5-62.5mg、GLAomega-6脂肪酸150-250mg、EPA/DHAomega-3脂肪酸525-875mg、钙300-500mg、铁11.25-18.75mg、镁150-250mg、锌15-25mg、碘112.5-187.5ug、铜750-1250ug、磷75-125mg、硒75-125ug、铬75-125ug、锰4.5-7.5mg、钾150-250mg、钼150-250ug、氯22.5-37.5mg、氟600-1000ug、镍4.5-7.5ug硅9-15ug、锡9-15ug、钒9-15ug、钴0.6-1ug。
上述配方中的原料都选择优质符合国家标准的上等原料，精心采购，严格把关，原料安全，质量优秀，含量标准。
本发明的成年人ABCODAC组合胶囊最佳营养补充剂即有大然营养素与人工合成营养素组合。分脂溶性液剂、水溶性粉剂、矿物质粉剂三种胶襄，制作成胶襄是为了提高人体的吸收。本发明的目的是为了让三类成年人各需不同的最佳营养摄入量，减去现有习惯的饮食营养摄入量，就是三类人群最佳营养补充量，让各种亚健康人群回到健康，让疾病人群提早康复，延长健康寿命。
本发明的成年人ABCODAC组合胶囊最佳营养补充剂是三类人群最佳的健康营养补充，是养生保健的最佳营养，具有益智、安神、养血、增目、固齿、乌发、美容、养颜、益脑、健肾、补阳、滋阴、抗衰、延年等补益治疗功能，还能降血压、保护心脑血管、调节内分泌、祛除致癌因素，具有高度抗氧化功能，增强各类器官的免疫功能，大幅提高人体的免疫力，防病治病，防癌抗癌，强身健体，益智防衰，延年益寿。
本发明的成年人ABCODAC组合胶囊是纯营养素组合，食用安全，方便，容易吸收，适宜各类人群。
下面结合实例，对本发明加以进一步说明
实例一：A型组合胶囊适宜成年人普健康与轻度亚健康人群，原料配方与制备：
维生素A：视黄醇800ug、β-胡萝卜素1200ug、维生素D 3ug、E150mg、K120ug、C800mg、B115mg、B215mg、B645mg、B1210ug、烟酰胺25mg、泛酸30mg、叶酸200ug、生物素30ug、胆碱30mg、肌醇30mg、GLAomega-6脂肪酸100mg、EPA/DHAomega-3脂肪酸250mg、钙200mg、铁6mg、镁50mg、锌6mg、碘60ug、铜300ug、磷25mg、硒25ug、铬25ug、锰2mg、钾100mg、钼100ug、氯10mg、氟400ug、镍4ug、硅8ug、锡8ug、钒8ug、钴0.4ug。
实例二：B型组合胶囊适宜成年人中度亚健康人群，原料配方与制备：
维生素A：视黄醇1600ug、β-胡萝卜素2400ug、维生素D 4ug、E200mg、K125ug、C1600mg、B125mg、B225mg、B660mg、B1220ug、烟酰胺30mg、泛酸50mg、叶酸300ug、生物素60ug、胆碱40mg、肌醇40mg、GLAomega-6脂肪酸150mg、EPA/DHAomega-3脂肪酸500mg、钙300mg、铁10mg、镁100mg、锌12mg、碘100ug、铜600ug、磷50mg、硒75ug、铬50ug、锰4mg、钾150mg、钼160ug、氯20mg、氟600ug、镍5ug、硅10ug、锡10ug、钒10ug、钴0.6ug。
实例三：C型组合胶囊适宜成年人重度亚健康与疾病人群，原料配方与制备：
维生素A：视黄醇2000ug、β-胡萝卜素3000ug、维生素D5ug、E300mg、K130ug、C2000mg、B135mg、B235mg、B675mg、B1230ug、烟酰胺40mg、泛酸100mg、叶酸400ug、生物素120ug、胆碱50mg、肌醇50mg、GLAomega-6脂肪酸200mg、EPA/DHAomega-3脂肪酸700mg、钙400mg、铁15mg、镁200mg、锌20mg、碘150ug、铜1000ug、磷100mg、硒100ug、铬100ug、锰6mg、钾200mg、钼200ug、氯30mg、氟800ug、镍6ug、硅12ug、锡12ug、钒12ug、钴0.8ug。
所述的一种成年人ABCODAC组合胶囊的制备工艺包括如下步聚：分别将脂溶性维生素的视黄醇、β-胡萝卜素、维生素D、E、K1和必须脂肪酸的GLAomega-6脂肪酸，EPA/DHAomega-3脂肪酸组合加工成油性软胶囊，将水溶性维生素的C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇加工成粉剂硬胶囊，分别将矿物质的钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴加工成粉剂硬胶囊。
A型组合胶囊：脂溶性2粒、水溶性2粒、矿物质2粒，共6粒组合。
B型组合胶囊：脂溶性2粒、水溶性2粒、矿物质2粒，共6粒组合。
C型组合胶囊：脂溶性3粒、水溶性3粒、矿物质3粒，共9粒组合。
最佳服用方式：6粒组合分二次服用，三种各一粒在早、午餐进食时服用，9粒组合分三次服用，三种各一粒在早、午、晚三餐进食时服用。每个组合的营养成分就是原料的营养成分，是各类人群每天必须补充的摄入量。
ABCODAC组合胶囊的研究成功，首先是国内专家的合作，又得到了国际最高权威英美专家的支持，是一个新世纪的健康大革命，是新世纪人类健康最佳营养补充的良方，是一个促使国人健康长寿，促进国家强盛发达科学发展的方向，国人健康，国家强盛。
关于ABC与ODAC的祥细说明：
ABC有二个含义，成年人与中老年人是代表A、B、C三种不同健康状况的人群，未成年人与幼少儿是代表A、B、C三种不同年龄段的人群。ODA是国际上(最佳营养)的简称，C是代表我们中国对(最佳营养)的研究。ABCDRIS与ABCODAC这两个姐妹项目是为中国建设健康城市的配套工程而设计研究的。
2007年福建省会城市福州已启动建设健康城市，我福建省百姓健康事业发展促进会是承办单位！
Claims (5)
1、所述的一种成年人ABCODAC组合胶囊最佳营养补充剂是以：维生素A：视黄醇、β-胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega-6脂肪酸，EPA/DHAomega-3脂肪酸，钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴38种营养素组合的全营养素保健食品。
2、A型组合胶囊适宜普健康与轻度亚健康人群，具体原料配方包括如下：
维生素A：视黄醇600-1000ug、β-胡萝卜素900-1500ug、维生素D2.25-3.75ug、E112.5-187.5mg、K115-25ug、C600-1000mg、B1 11.25-18.75mg、B2 11.25-18.75mg、B633.75-56.25mg、B127.5-12.5ug、烟酰胺18.75-31.25mg、泛酸22.5-37.5mg、叶酸150-250ug、生物素22.5-37.5ug、胆碱22.5-37.5mg、肌醇22.5-37.5mg、GLAomega-6脂肪酸75-125mg、EPA/DHAomega-3脂肪酸187.5-312.5mg、钙150-250mg、铁4.5-7.5mg、镁37.5-62.5mg、锌4.5-7.5mg、碘45-75ug、铜225-375ug、磷18.75-31.25mg、硒18.75-31.25ug、铬18.75-31.25ug、锰1.5-2.5mg、钾75-125mg、钼75-125ug、氯7.5-12.5mg、氟300-500ug、镍3-5ug、硅6-10ug、锡6-10ug、钒6-10ug、钴0.3-0.5ug。
3、B型组合胶囊适宜中度亚健康人群，具体原料配方包括如下：
维生素A：视黄醇1200-2000ug、β-胡萝卜素1800-3000ug、维生素D3-5ug、E150-250mg、K118.75-31.25ug、C1200-2000mg、B118.75-3125mg、B218.75-31.25mg、B645-75mg、B1215-25ug、烟酰胺22.5-37.5mg、泛酸37.5-62.5mg、叶酸225-375ug、生物素45-75ug、胆碱30-50mg、肌醇30-50mg、GLAomega-6脂肪酸112.5-187.5mg、EPA/DHAomega-3脂肪酸375-625mg、钙225-375mg、铁7.5-12.5mg、镁75-125mg、锌9-15mg、碘75-125ug、铜450-750ug、磷37.5-62.5mg、硒56.25-93.75ug、铬37.5-62.5ug、锰3-5mg、钾112.5-187.5mg、钼120-200ug、氯15-25mg、氟450-750ug、镍3.75-6.25ug、硅7.5-12.5ug、锡7.5-12.5ug、钒7.5-12.5ug、钴0.45-0.75ug。
4、C型组合胶囊适宜重度亚健康与疾病人群，具体原料配方包括如下：
维生素A：视黄醇1500-2500ug、β-胡萝卜素2250-3750ug、维生素D3.75-6.25ug、E225-375mg、K122.5-37.5ug、C1500-2500mg、B126.25-43.75mg、B226.25-43.75mg、B656.25-93.75mg、B1222.5-37.5ug、烟酰胺30-50mg、泛酸75-125mg、叶酸300-500ug、生物素90-150ug、胆碱37.5-62.5mg、肌醇37.5-62.5mg、GLAomega-6脂肪酸150-250mg、EPA/DHAomega-3脂肪酸525-875mg、钙300-500mg、铁11.25-18.75mg、镁150-250mg、锌15-25mg、碘112.5-187.5ug、铜750-1250ug、磷75-125mg、硒75-125ug、铬75-125ug、锰4.5-7.5mg、钾150-250mg、钼150-250ug、氯22.5-37.5mg、氟600-1000ug、镍4.5-7.5ug、硅9-15ug、锡9-15ug、钒9-15ug、钴0.6-1ug。
5、权利要求1所述一种成年人ABCODAC组合胶囊最佳营养补充剂的制作工艺包括如下步聚：
分别将脂溶性维生素的视黄醇、β-胡萝卜素、维生素D、E、K1和GLAomega-6脂肪酸，EPA/DHAomega-3脂肪酸加工成油性软胶襄。
分别将水溶性维生素的C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇加工成粉剂硬胶襄。
分别将矿物质的钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴加工成粉剂硬胶襄。
A型组合胶囊：将脂溶性维生素的视黄醇、β-胡萝卜素、维生素D、E、K1和GLAomega-6脂肪酸。EPA/DHAomega-3脂肪酸加工成2粒0.4克容量的软胶囊，将水溶性维生素的C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇加工成2粒0.5克容量的粉剂硬胶囊。将矿物质的钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴加工成2粒0.3克容量的粉剂硬胶囊。A型组合胶襄各类3种共计6粒为A型普健康与轻度亚健康人群一天的补充量。
B型组合胶囊：将脂溶性维生素的视黄醇、β-胡萝卜素、维生素D、E、K1和GLAomega-6脂肪酸。EPA/DHAomega-3脂肪酸加工成2粒0.6克容量的软胶囊，将水溶性维生素的C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇加工成2粒0.6克容量的粉剂硬胶囊。将矿物质的钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍、硅、锡、钒、钴加工成2粒0.4克容量的粉剂硬胶襄。B型组合胶囊各类3种共计6粒为B型中度亚健康人群一天的补充量。
C型组合胶囊：将脂溶性维生素的视黄醇、β-胡萝卜素、维生素D、E、K1和GLAomega-6脂肪酸。EPA/DHAomega-3脂肪酸加工成3粒0.6克容量的软胶囊，将水溶性维生素的C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇加工成3粒0.5克容量的粉剂硬胶囊。将矿物质的钙、铁、镁、锌、碘、铜、磷、硒、铬、锰、钾、钼、氯、氟、镍硅、锡、钒、钴加工成3粒0.4克容量的粉剂硬胶囊。C型组合胶襄各类3种共计9粒为C型重度亚健康与疾病人群一天的补充量。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100717540A CN101675806B (zh) | 2008-09-16 | 2008-09-16 | 一种成年人组合胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100717540A CN101675806B (zh) | 2008-09-16 | 2008-09-16 | 一种成年人组合胶囊 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101675806A true CN101675806A (zh) | 2010-03-24 |
| CN101675806B CN101675806B (zh) | 2013-12-11 |
Family
ID=42028646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100717540A Expired - Fee Related CN101675806B (zh) | 2008-09-16 | 2008-09-16 | 一种成年人组合胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101675806B (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816428A (zh) * | 2010-05-13 | 2010-09-01 | 山东森健生物科技发展有限公司 | 一种可以使人体达到均衡营养的保健食品 |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| CN103766890A (zh) * | 2012-10-22 | 2014-05-07 | 孙烈 | 一种正分子营养运动员教练员专用营养口服液 |
| CN106692626A (zh) * | 2017-01-18 | 2017-05-24 | 范祖强 | 一种增强免疫力的黑蒜精华液及其制备方法 |
| CN107125769A (zh) * | 2017-05-31 | 2017-09-05 | 于浩泳 | 代谢手术术后营养补充复合制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1422553A (zh) * | 2001-12-06 | 2003-06-11 | 上海黄金搭档生物科技有限公司 | 女士维生素、矿物质营养组合物 |
| CN1593229A (zh) * | 2004-07-09 | 2005-03-16 | 曹永文 | 生物营养保健素及制作方法及含有生物营养保健素的产品 |
| JPWO2006070453A1 (ja) * | 2004-12-28 | 2008-06-12 | フォーデイズ株式会社 | 健康ドリンク |
-
2008
- 2008-09-16 CN CN2008100717540A patent/CN101675806B/zh not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816428A (zh) * | 2010-05-13 | 2010-09-01 | 山东森健生物科技发展有限公司 | 一种可以使人体达到均衡营养的保健食品 |
| CN101816428B (zh) * | 2010-05-13 | 2012-05-23 | 山东森健生物科技发展有限公司 | 一种可以使人体达到均衡营养的保健食品 |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| US8545896B2 (en) | 2011-09-29 | 2013-10-01 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| CN103766890A (zh) * | 2012-10-22 | 2014-05-07 | 孙烈 | 一种正分子营养运动员教练员专用营养口服液 |
| CN106692626A (zh) * | 2017-01-18 | 2017-05-24 | 范祖强 | 一种增强免疫力的黑蒜精华液及其制备方法 |
| CN107125769A (zh) * | 2017-05-31 | 2017-09-05 | 于浩泳 | 代谢手术术后营养补充复合制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101675806B (zh) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101675805B (zh) | 一种中老年人组合胶囊 | |
| CN101675806B (zh) | 一种成年人组合胶囊 | |
| Ross et al. | The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know | |
| Lutter et al. | Nutritional status of infants and young children and characteristics of their diets | |
| CN101675804B (zh) | 一种未成年人组合胶囊 | |
| US20080193565A1 (en) | Dietary supplement containing Alkaline Electrolyte buffers | |
| Ahmed et al. | Protein-energy malnutrition in children | |
| Watson | Handbook of vitamin D in human health: prevention, treatment and toxicity | |
| Spirichev | To the substantiation of the joint use of vitamin D and the rest of the 12 vitamins necessary for the creation and realization of the vital functions of its hormone-active form (the vitamin D+ 12 vitamins approach) | |
| WO2013116062A1 (en) | Salt replacement compositions and methods of using same | |
| WO2017179707A1 (ja) | フレイル改善用組み合わせ物 | |
| CN103622035A (zh) | 提高免疫和改善精力同时解决维生素和矿物质缺乏的多种维生素/矿物质制剂 | |
| CN101675803B (zh) | 一种幼少儿人群复合冲剂 | |
| Dror et al. | Recommended micronutrient supplementation for institutionalized elderly | |
| Torkos | The Canadian encyclopedia of natural medicine | |
| Dayal et al. | Vitamin D deficiency: Dealing with the current epidemic | |
| Jo et al. | A comparative study on food habits and nutrient intakes with body mass index of hypertensive patients commuting to a local health center | |
| Gonzalez | Vitamin D supplementation: An update | |
| Lawal et al. | Phytomenadione as a dietary supplement: Sources and health benefits | |
| US9357797B2 (en) | Dietary supplement containing alkaline electrolyte buffers | |
| Laxmi et al. | Prevalence of Vitamin D Deficiency in Lalitpur Nepal | |
| CN103766890A (zh) | 一种正分子营养运动员教练员专用营养口服液 | |
| CN103704684A (zh) | 一种骨骼保健品 | |
| CN103766891A (zh) | 一种正分子营养青少年学生专用营养口服液 | |
| Shahapurkar et al. | A REVIEW ON THE NUTRITIONAL VALUE AND POTENTIAL HEALTH BENEFITS OF SPIRULINA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: payment instructions |
|
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: Notice of Termination of Patent Rights |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131211 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |